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A B S T R A C T
Autism is a dramatically expanding public health challenge. The search for genomic
variants underlying the disease concomitantly accelerated over the last 5 years, leading to a
general consensus that genetics can explain between 40% and 60% of the symptomatic
variability seen in autism. This stresses both an urgent need to continue devoting resources
to the search for genetic etiologies that deﬁne the forms of autism, and an equal need for
attention to the interactive roles of the environment. While some environmental factors
have been investigated, few studies have attempted to elucidate the combination and
interplay between gene and environment to gain clear understanding of the mechanisms
by which environmental factors interact with genetic susceptibilities in Autism Spectrum
Disorder. Due to ﬁnancial constraints as well as recruitment protocols limited by
geography, such studies have been challenging to implement. We discuss here how
crowdsourcing approaches can overcome these limitations.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Despite its rising prevalence, the causes of autism, likely a combination of genetic and environmental factors, remain
unclear. Because autism appears to be a highly heritable condition, numerous high-powered efforts have banked genomic
data on thousands of carefully phenotyped individuals in the pursuit of genetic markers to explain the molecular pathologies
of autism. These large genomic efforts are collectively starting to sharpen the molecular picture of autism, which now
includes at least 60 genes harboring variants of high interest (De Rubeis et al., 2014; Iossifov et al., 2014; Robinson et al.,
2016). This work has led to the understanding that inherited variation from both common and rare alleles explains
approximately 40% of the risk for developing autism (95% conﬁdence interval: 8%–84%, estimated via the squared correlation
of outcome with predicted probabilities from logistic regression) (Stein, Parikshak, & Geschwind, 2013).
The environment – e.g., environment of the cell, brain, child, and/or parents – must explain a sizable amount of the
remainder, potentially as much as 60%. However, studies of the environmental contributions to autism lag far behind studies
of the genome. This is due at least in part to the difﬁculties in design of well controlled studies, challenges with recruitment,
costs due to need for large sample sizes, and choice of environmental factor on which to focus, to name a few. Faced with
these challenges, the ﬁeld has demonstrated statistically signiﬁcant, but still tenuous links to several factors. For example,
systematic exploration of almost 20 years (1984–2003) of medical records from over 400,000 subjects in Sweden has
pinpointed advanced parental age as associated with increased risk of autism, particularly for autism with intellectual
disability (Idring et al., 2014). Nationwide registered medical records from Denmark revealed links to increased risk of ASD
diagnosis in the offspring from maternal infection during pregnancy, speciﬁcally viral infection during the ﬁrst trimester and
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M.M. David et al. / Research in Autism Spectrum Disorders 32 (2016) 80–83 81acterial infection during the second trimester, (Atladóttir et al., 2010). Shelton et al. found the proximity of agricultural
esticide during pregnancy associated with autism by linking the physical addresses of almost a thousand participants with
e data from commercial pesticide application (Shelton et al., 2014). Several studies have also shown that fetal exposure to
e valproic acid (a drug used to prevent epilepsy), which can be teratogenic, may lead to autism (Chomiak, Turner, & Hu,
013; Williams et al., 2001). Finally, the growing understanding of a role for the gut microbiome in behavioral disorders, i.e.
e “gut-brain” axis, cannot be ignored; numerous studies have reported microbial taxa speciﬁc to autism (Kang et al., 2013;
acfabe, Cain, Boon, Ossenkopp, & Cain, 2011; Finegold et al., 2010). Mouse models of autism with aytpical microbiota
ompositions compared to control can revert to typical ﬂoral compositions through treatment with the human commensal
acteroides fragilis. This ingestion of probiotics also rectiﬁed gut permeability, microbial composition, and ameliorated
eﬁcits in communicative, stereotypic, anxiety-like and sensorimotor behaviors (Hsiao et al., 2013), supporting the potential
ole of environmental factors in the onset and maintenance of autism-related behaviors.
It is clear that neither the genome nor the environment alone will explain the underlying causes of autism, yet the
esearch on environmental and genetic factors remain decoupled. This decoupled state of our autism data presents a
ubstantial barrier to initializing the parameters of the G(genome) + E(environment) = P(phenotype) equation. However,
oupling of the two requires: I. a reasonable selection of environmental measures, II. prospective recruitment of large and
ell-controlled study participants, III. robust recruitment infrastructure, and IV. enormous ﬁnancial support, particularly if
one in prospective clinical trials.
In order to overcome these challenges and unravel speciﬁc mechanisms related to the differential impact of the
nvironment with speciﬁc genetic variants, several researchers have successfully chosen targeted approaches. For example,
sing data from dizygotic twins, it has been shown that beta2-adrenergic receptor can be differentially affected by exposure
 neuro-active drugs, and is signiﬁcantly associated with the autism phenotype (Connors et al., 2005). Furthermore, several
tudies have demonstrated than mutations in the SERT gene (encoding for serotonin transporter) result in increased anxiety
 adult life when combined with a stressful environment during development (Gross & Hen, 2004; Lesch, 2001), and that
ng/short allele polymorphism upstream of the same gene coupled with prenatal stress is associated with a decrease of
ocial interaction in mice, producing autism-like behaviors in offspring (Jones et al., 2010). Other examples from animal
odels include work investigating the interaction between genetic background of an inbred mouse strain with an
nvironmental insult, which revealed increased severity of the behavioral phenotype in genetically susceptible mice treated
ith an immune challenge in utero (Schwartzer et al., 2013).
While targeted studies have helped to pinpoint interactions between environmental factors and individual genes, there is
 pressing need for projects that measure both environmental factors and genetic variations across the whole genome.
tandard prospective clinical trials no longer represent a viable avenue for making clinically valuable discoveries at the cross
ection of the environment and the genome. The sample size to achieve sufﬁcient power is in the tens of thousands of
dividuals, making time and costs both out of bounds. A standard prospective clinical trial approach would, need to engage
ultiple clinical sites, substantial clinical coordination across sites, and a coordinated data collection infrastructure. The
ractical challenges to effective recruitment, phenotyping, and data collection are enormous. Untangling interaction
etween genome and environment will also require rigorous statistical standards, and the development of methods to
etermine appropriate correction and models to use, as existing methods for discovery of gene(G)  environment(E)
teraction are known to have low power, particularly when one corrects for testing multiple variations across the genome.
ne solution already suggested could be to apply a ﬁlter step in order to select the variants most likely to be involved in a
  E interaction (Zhang, Lewinger, Conti, Morrison, & Gauderman, 2016), or aggregating information from multiple loci
cross a genetic region (Fan & Lo, 2013). In order to apply any of these methods and amalgamate ample data we must look for
ther, less difﬁcult ways to collect data to couple the environment with the genome in order complete the G x E = P equation:
ere is promise in crowdsourcing.
Families with autism are overwhelmingly willing to participate in online research efforts, with networks like Interactive
utism Network, Autism Match and MyAutismTeam, representing a potential untapped opportunity for acquisition of big
ata. The scientiﬁc research community may therefore be able to use online approaches, leverage social networks and
atient-advocacy groups to enroll thousands of internet-active families with children on the autism spectrum quickly,
nhancing our recruitment efforts via completely crowdsourced clinical studies. Crowdsourced approaches to biological
ata collection through web portalsare starting to show promise of speed, accuracy, and size, including for example, The
merican Gut Program, which recruited over 4200 participants in 1.5 years, harvesting both participant metadata and
roviding open access to the sequencing results. As an ancillary byproduct, social network recruitment has potential for
ngitudinal retention of subjects, which enables tracking of progress during therapeutic programs that often have
normous but still largely unmeasured beneﬁts. In the same vein, Apple introduced an open-source framework called Apple
esearchKit that allows researchers to create powerful applications for medical research. Similar efforts have emerged in the
utism community itself including the Simons Foundation SPARK initiative to recruit 50,000 individuals with autism via the
rowd and the Early Life Exposures Assessment Tool developed by Autism Speaks in order to collect environmental exposure
ata.
Among the numerous advantages afforded by this approach are substantial cost reductions by eliminating the need for
hysical space and onsite clinical staff, time savings afforded toe participants and their families, and the comfort and
implicity of acquiring samples remotely, i.e. directly from the patients’ homes and on their own schedules. Furthermore, this
pproach reduces the overhead costs per study participant without restricting the information that can be gathered,
82 M.M. David et al. / Research in Autism Spectrum Disorders 32 (2016) 80–83enabling recruitment of very large and statistically powerful cohorts. Scientists will be able to generate better patient groups,
with less concern that overly stringent study criteria will preclude sufﬁcient recruitment. Finally, this approach allows the
analysis of metadata, such as cross-referencing patient addresses with maps of environmental factors such as pollution,
arriving faster to sharpened hypothesis that can be tested individually in more traditional ways at a far more manageable
pricepoint.
Crowdsourced approaches are not without challenges. One concern in employing these approaches to examine causes of
autism is the lack of personal interactions in our model. As we rely on self-reporting of the participants, we need to ensure
that the self-reported diagnosis is clinically reliable (Kohane & Eran, 2013). There are several approaches to provide a risk
assessment for autism that are compatible with an online interface and remote interaction. The Interactive Autism Network
(IAN) for example was able to validate the use of self-reported professional autism diagnosis to the registry's database
(Daniels et al., 2012) (Lee et al., 2010). Machine learning classiﬁcation of parent reported information and features extracted
from short home recordings of the child's behaviors have shown promise for remote detecion and screening (Duda et al.,
2014; Fusaro et al., 2014; Kosmicki et al., 2015; Wall et al., 2012). Such classiﬁers can be run quickly to produce a score that
indicates both conﬁdence in the classiﬁcation and phenotypic severity with acceptably high accuracy relative to the clinical
best estimate (Duda et al., 2016) and are therefore useful as conﬁrmatory support for the self-reported diagnosis. Such an
approach has advantages due to its crowdsourcing capability, allowing online phenotyping to minimize time while
maximizing recruitment reach, but also because the home videos provide persistent digital observations of the children in
their natural environment, where behaviors can deviate in important ways from those exhibited in the clinic.
Regardless, biases in self-reported information still could easily undermine the beneﬁts of rapid and large scale data
acquisition from the crowd to power larger studies that address the complexity of autism as a genetic and environmental
disorder. Deviations between self-report and medical records data have been shown, for example, self-report of antibiotic
intake differs from the same kind of reporting captured within an electronic medical record (Caverly et al., 2016). Such
potential deviation must be controlled through creative platform design. Ideally, the design will engage sensors on
ubiquitous devices (e.g., smartphones) that can record objective measures in increasingly more passive ways, and/or by
defaulting wherever feasible to the capture of direct observations (e.g. images, videos) rather than surveys alone (Stark,
Kumar, Longhurst, & Wall, 2016). This will safeguard against such factors like unpredictable variations in subjective reporting
and survey fatigue that often plague the crowd-questionnaire approach. The efforts of researchkit and researchstack from
Apple and Google, respectively, highlight the attention now being paid to ﬁnding the right platform design to empower the
crowd approach and suggest that we will soon have further demonstration that the mobilized crowd can augment the
standards in place today to dramatically accelerate discovery.
Another potential drawback of crowd methods for data acquisition is the potential for bias against populations that do not
have easy access to mobile technology, especially lower income populations and the elderly. This concern also exists for
classical clinical trials, wherein caregivers raising a child with special needs are required to spend hours at a clinic during
business hours near the clinics that may be geographically disconnected from important sectors of the study population.
Given the increasing ubiquity of access to technology, it is likely that crowdsourced studies will be signiﬁcantly more
accessible to diverse social and economic groups than than classical trials. However, inclusion of such groups must become
explicit components of the design and form factor for any mobile, crowd-based study.
Despite the challenges and potential concerns, we believe that a sandbox of highly coupled data constitute a powerful
way to parse the complexity of autism into subcomponents that have detectable diagnostic markers, prognostic markers,
and that reveal targets for therapeutic intervention.The literature has focused largely on gene-by-environment interaction,
where the environmental variable and the gene tested were hypothesized a priori. Conclusions were drawn from a candidate
gene or G X E association, resulting often in pertinent and useful discovery but sometimes difﬁcult to replicate (Duncan &
Keller, 2011). However, large data-driven studies using a combination of GWAS (Genome-wide Association Study) and EWAS
(Environment-wide Association Study) were able to spot genes and factors of interest linked to environmental variables,
stressing the importance of building larger and more encompassing databases (Nickels et al., 2013; Patel, Chen, & Butte,
2012).
Reaching that global scale and constructing a sandbox of data of the size needed to parse the complexity of autism will
require recruitment of thousands of individuals. Arguably the most effective way to get thousands to participate is to reach
out to families across the world through a new avenue of recruitment, social media and the autism crowd. To build this
sandbox of coupled data we need to look beyond our standard methods of clinical studies and begin to utilize new
technologies to engage families across the globe affected by autism. Increasing participation through crowdsourcing will
lead to large data sets that can allow the unbiased detection of relevant factors contributing to the autism phenotype. For
example, triangulating data and phenotype with environmental factors may unravel any association autism has with
potential chemical exposure. These factors can be further tested using targeted approaches, likely leading to robust and
replicable ﬁndings that can be more efﬁciently translated into therapeutic approaches.
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